SILVIA SILVA DULUC: Open Payments
NPI 1548291834 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$998 in 45 payments from 14 companies in 2025. Trend: 2023 $1,130 · 2024 $1,194 · 2025 $998
Food & beverage: $998
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $170 |
| Teva Pharmaceuticals USA, Inc. | 8 | $138 |
| Alkermes, Inc. | 6 | $132 |
| Almatica Pharma LLC | 5 | $96 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| E.R. Squibb & Sons, L.L.C. | 3 | $80 |
| Tris Pharma Inc | 3 | $69 |
| Lundbeck LLC | 2 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 2 | $38 |
Products named: Auvelity, REXULTI, ARISTADA, LOREEV XR, AUSTEDO XR, COBENFY, Dyanavel XR, UZEDY.
Industry payments across FL — which companies pay providers there.
